Macroscopic assessment of mesorectal excision in rectal cancer: A useful tool for improving quality control in a multidisciplinary team

Cancer

Volumn 115, Issue 15, 2009, Pages 3400-3411

  García Granero, Eduardo ^a,b   Faiz, Omar ^a   Muñoz, Elena ^a   Flor, Blas ^a   Navarro, Samuel ^a   Faus, Carmen ^a   García Botello, Stephannie Anne ^a   Lledó, Salvador ^a   Cervantes, Andrés ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE   (Spain)

Author keywords

Audit of surgical quality; Multidisciplinary treatment; Rectal cancer; Total mesorectal excision

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CLINICAL EVALUATION; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECTAL NEOPLASMS; RECTUM; TREATMENT OUTCOME;

EID: 68149150883     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24387     Document Type: Article

References (38)

1. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181:335-346.
2. Heald RJ, Moran BJ, Ryall RD, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133:894-899.
3. Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142-1149.
4. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45:857-866.
5. Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351-357.
6. Cervantes A, Rodriguez-Braun E, Navarro S, et al. Integrative decisions in rectal cancer. Ann Oncol. 2007;18(suppl 9):ix127-ix131.
7. Holm T, Johansson H, Cedermark B, et al. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg. 1997;84:657-663.
8. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol. 1999;25:368-374.
9. Nagtegaal ID, van de Velde CJ, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-1734.
10. Martling A, Cedermark B, Johansson H, et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002;89:1008-1013.
11. Hermanek P. Impact of surgeon's technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum. 1999;42:559-562.
12. Hermanek P, Hermanek P, Hohenberger W, et al. The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis. 2003;18:335-341.
13. Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol. 2003;4:695-702.
14. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999.
15. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344:707-711.
16. de Haas-Kock DF, Baeten CG, Jager JJ, et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg. 1996;83:781-785.
17. Quirke P. Limitations of existing systems of staging for rectal cancer: the forgotten margin. In: Soreide O, Norstein J, eds. Rectal Cancer Surgery: Optimisation, Standardisation, Documentation. Berlin, Germany: Springer-Verlag; 1997:63-81.
18. Quirke P, Morris E. Reporting colorectal cancer. Histopathology. 2007;50:103-112.
19. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.
20. Quirke P, Steele R, Monson J, Grieve R, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG C016 randomised clinical trial. Lancet 2009;373:821-828.
21. Maslekar S, Sharma A, Macdonald A, et al. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007;50:168-175.
22. Jeyarajah S, Sutton CD, Miller AS, Hemingway D, Leicester Colorectal Specialist Group. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis. 2007;9:808-815.
23. Royal College of Pathologists. Dataset for Colorectal Cancer. 2nd ed. Available at: http://www.rcpath.org/resources/pdf/G049-ColorectalDataset-Sep07. pdf Accessed on September 30, 2008.
24. The Association of Coloproctology of Great Britain and Ireland. Resources for coloproctology. 2006. Available at: http://www.acpgbi.org.uk/assets/ documents/resources-June-2006.pdf Accessed on September 30, 2008.
25. The Association of Coloproctology of Great Britain and Ireland. Guidelines for the management of colorectal cancer. 3rd ed. 2007. Available at: http://www.acpgbi.org.uk/assets/documents/COLO-guides.pdf Accessed on September 30, 2008.
26. Garcia-Granero E, Marti-Obiol R, Gomez-Barbadillo J, et al. Impact of surgeon organization and specialization in rectal cancer outcome. Colorectal Dis. 2001;3:179-184.
27. Nagtegaal ID, van de Velde CJ, Marijnen CA, et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257-9264.
28. Holm T, Ljung A, Haggmark T, et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94:232-238.
29. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26:3481-3482.
30. Rullier E, Sa Cunha A, Couderc P, Rullier A, Gontier R, Saric J. Laparoscopic intersphincteric resection with coloplasty and coloanal anastomosis for mid and low rectal cancer. Br J Surg. 2003;90:445-451.
31. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O; Norwegian Rectal Cancer Group. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004;47:48-58.
32. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74-82.
33. den Dulk M, Marijnen CA, Putter H, et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg. 2007;246:83-90.
34. Tilney HS, Tekkis PP, Sains PS, et al. Factors affecting circumferential resection margin involvement after rectal cancer excision. Dis Colon Rectum. 2007;50:29-36.
35. Heald RJ, Smedh RK, Kald A, et al. Abdominoperineal excision of the rectum - an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum. 1997;40: 747-751.
36. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779-784.
37. Nagtegaal ID, Gosens MJ, Marijnen CA, et al. Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. J Clin Oncol. 2007;25:1647-1650.
38. Kelly MJ, Lloyd TD, Marshall D, et al. A snapshot of MDT working and patient mapping in the UK colorectal cancer centres in 2002. Colorectal Dis. 2003;5:577-581.